Navigation Links
UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012
Date:10/25/2011

AMSTERDAM, Oct. 26, 2011 /PRNewswire/ -- CPhI Worldwide -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced the introduction of a new event, ICSE USA, to be held from May 22-23, 2012 at the Pennsylvania Convention Centre in Philadelphia. ICSE USA extends an established global line-up of International Contract Services Expo (ICSE) events which are held annually and will focus on the pharmaceutical contract services and outsourcing sectors in the US market.

The introduction of ICSE USA in 2012 comes as a direct response to feedback from 60.2% of ICSE Europe 2010 visitors, who indicated that the North America region is their strongest target for the development of business over the next three years. The exhibitor profile will include companies specialising in custom manufacturing, biotechnology, clinical trials from phase I to IV, IT services, contract research, drug discovery, laboratory services, logistics services, marketing services and R&D. ICSE USA will compliment these offerings with educational sessions and networking opportunities targeted around both attendee and exhibitor needs.

In 2010 the global value of outsourced pharmaceutical trials run through Contract Research Organisations amounted to an estimated $19bn. According to the US National Institutes of Health about 50% of all clinical trials are currently done in the USA and there are projections for this to continue to grow 9-11% annually. The costs of running clinical trials in the US are about twice as high as in countries like China, India and Russia which will raise the needs for outsourcing from the United States. Currently about 60% of this work is outsourced, and over time this is expected to experience compounded annual growth of 12% to $33bn in 2015(1).

ICSE USA will run simultaneously with Pharmapack North America, another new event hosted by UBM and focusing on drug devices, delivery systems and packaging solutions, as well as East Pack which offers the premier industry resource for East Coast packaging and manufacturing sectors. The events will also be collocated with Medical Design & Manufacturing (MD&M) East which is the longest running medical design and manufacturing event in the world. The combined events will capitalise on cross over traffic and the synergies between the shows with the aim of strengthening existing relationships while creating additional business opportunities for attendees and exhibitors alike.

"As US companies' race against the expiration of blockbuster drugs, there has been a huge push towards the development of biosimilars and biologics to fill the needs of the market. Coupled with the introduction of the Patient Protection and Affordable Care Acts, which highlight the need to make quality pharmaceuticals more accessible to all citizens, all of these factors have created a massive drive for R&D in the US market. Running R&D and clinical trials in the US is expensive and directly increases the demand for comprehensive contract and outsourcing resources in this market," said Haf Cennydd, Global Brand Director of ICSE. She went on to note, "Despite tough market conditions, the US remains the largest pharmaceutical market in the world, accounting for 39% of the total $795bn generated by Pharma annually. It is expected to continue to grow at an average rate of 5% per year, leading to a market value of $399bn in 2015(1)."

The UBM Live annual schedule of ICSE events also includes India (30 November – 2 December, Bombay Exhibition Centre, Mumbai, India, 2011), Japan (21-23, March, Big Sight Tokyo Exhibition Center, Japan, 2012), China (26-28, June, SNIEC, Shanghai, China, 2012), South America (21-23, August, Transamerica Expo Centre, Sao Paulo, Brazil 2012) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).

(1)Pharma Outsourcing in the USA, UBM commissioned report by Jan Ramakers of the Fine Chemical Group

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers Access to Lower-Cost Generic Drugs
2. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
3. WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release
4. Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry
5. Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality
6. Webcast Alert: Isis Pharmaceuticals Third Quarter 2011 Financial Results Conference Call
7. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
8. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
9. Vanda Pharmaceuticals Appoints Chief Commercial Officer
10. Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis®
11. Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):